198 related articles for article (PubMed ID: 32958237)
1. The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates.
Scialò C; Legname G
Prog Mol Biol Transl Sci; 2020; 175():297-323. PubMed ID: 32958237
[TBL] [Abstract][Full Text] [Related]
2. On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases.
Legname G; Scialò C
Prion; 2020 Dec; 14(1):257-270. PubMed ID: 33345731
[TBL] [Abstract][Full Text] [Related]
3. Role of cellular prion protein in interneuronal amyloid transmission.
Del Río JA; Ferrer I; Gavín R
Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
5. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
[TBL] [Abstract][Full Text] [Related]
6. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
7. Sensing α-Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration.
Brás IC; Lopes LV; Outeiro TF
Mov Disord; 2018 Nov; 33(11):1675-1684. PubMed ID: 30423195
[TBL] [Abstract][Full Text] [Related]
8. Different tau fibril types reduce prion level in chronically and de novo infected cells.
Celauro L; Burato A; Zattoni M; De Cecco E; Fantuz M; Cazzaniga FA; Bistaffa E; Moda F; Legname G
J Biol Chem; 2023 Aug; 299(8):105054. PubMed ID: 37454740
[TBL] [Abstract][Full Text] [Related]
9. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
10. PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins.
Corbett GT; Wang Z; Hong W; Colom-Cadena M; Rose J; Liao M; Asfaw A; Hall TC; Ding L; DeSousa A; Frosch MP; Collinge J; Harris DA; Perkinton MS; Spires-Jones TL; Young-Pearse TL; Billinton A; Walsh DM
Acta Neuropathol; 2020 Mar; 139(3):503-526. PubMed ID: 31853635
[TBL] [Abstract][Full Text] [Related]
11. Soluble Aβ aggregates can inhibit prion propagation.
Sarell CJ; Quarterman E; Yip DC; Terry C; Nicoll AJ; Wadsworth JDF; Farrow MA; Walsh DM; Collinge J
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29142106
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication.
Aulić S; Masperone L; Narkiewicz J; Isopi E; Bistaffa E; Ambrosetti E; Pastore B; De Cecco E; Scaini D; Zago P; Moda F; Tagliavini F; Legname G
Sci Rep; 2017 Aug; 7(1):10050. PubMed ID: 28855681
[TBL] [Abstract][Full Text] [Related]
13. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
[TBL] [Abstract][Full Text] [Related]
14. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
Sarnataro D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819
[TBL] [Abstract][Full Text] [Related]
15. Cellular prion protein mediates toxic signaling of amyloid beta.
Resenberger UK; Winklhofer KF; Tatzelt J
Neurodegener Dis; 2012; 10(1-4):298-300. PubMed ID: 22156337
[TBL] [Abstract][Full Text] [Related]
16. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
17. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
[TBL] [Abstract][Full Text] [Related]
18. Invited Review: The role of prion-like mechanisms in neurodegenerative diseases.
Jaunmuktane Z; Brandner S
Neuropathol Appl Neurobiol; 2020 Oct; 46(6):522-545. PubMed ID: 31868945
[TBL] [Abstract][Full Text] [Related]
19. Preferential Recruitment of Conformationally Distinct Amyloid-β Oligomers by the Intrinsically Disordered Region of the Human Prion Protein.
Madhu P; Mukhopadhyay S
ACS Chem Neurosci; 2020 Jan; 11(1):86-98. PubMed ID: 31808343
[TBL] [Abstract][Full Text] [Related]
20. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
